GSK Harnesses Greater Bay Area's 88 Million Residents' Health Data to Accelerate Drug Development
SCMP · 1 SOURCESabout 3 hours ago2 MIN
Summary
GSK is tapping into health data from the Greater Bay Area's 88 million residents to accelerate drug development, with a focus on vaccines and cancer treatments. The pharmaceutical company signed a memorandum of understanding with the University of Hong Kong and the Greater Bay Area International Clinical Trial Institute last September to study the long-term health effects of the shingles vaccine. GSK Hong Kong and Macau General Manager Nicholas Teo said patient data could provide crucial supplementary evidence to support regulatory filings and potential label expansions.
Key Points
- GSK will utilize patient data from 88 million residents across the Greater Bay Area's 11 cities, including Hong Kong, Macau, and nine cities in Guangdong province
- The company signed an MoU in September last year with the University of Hong Kong and the Greater Bay Area International Clinical Trial Institute on a shingles vaccine study
- GSK Hong Kong and Macau General Manager Nicholas Teo emphasized that patient data forms supplementary evidence for regulatory filings and label expansions
- Research areas include shingles, respiratory syncytial virus, hepatitis B, oncology, and haematology
- Scientists are studying potential cardiovascular and neurological benefits of existing vaccines such as flu and shingles shots
- The Greater Bay Area's combined GDP exceeded US$2.23 trillion last year
Why It Matters
The cross-border data partnership represents a significant step toward deeper medical integration between Hong Kong and mainland China, potentially setting a precedent for future pharmaceutical collaborations that could benefit patients across the region .
The cross-border data partnership represents a significant step toward deeper medical integration between Hong Kong and mainland China, potentially setting a precedent for future pharmaceutical collaborations that could benefit patients across the region .